Welcome to your forever-expanding library of evidence-based research summaries, practical support resources, and embodied thriving work created by and for people living with a cancer diagnosis.

Explore in A–Z Order

This page serves as the main A–Z directory of the site's major sections, support resources, and discussion indexes. As more topics are added, they will be slotted into this list alphabetically. Each link takes you to the most relevant section hub, overview page, deep dive, or discussion index.

Jump to: A · B · C · D · E · F · G · H · I · J · K · L · M · N · O · P · Q · R · S · T · U · V · W · X · Y · Z

A

• About Abbey the Founder — Meet Abbey Mitchell, founder of My Healing Community: her lived experience with metastatic breast cancer, research-led patient advocacy, community work, and the purpose behind the free resources shared here.

• Apigenin in Oncology — Evidence-based guide to apigenin in oncology, covering BCL-2 survival proteins, tumour signalling, senescence and SASP, immune effects, chemosensitisation, research by cancer-type, bioavailability, dosing, and safety.

• Aspirin in Oncology — Evidence-based guide to aspirin in oncology, covering COX and platelet biology, tumour and immune mechanisms, cancer-specific evidence, PIK3CA-mutated colorectal cancer, dosing, bleeding risk, and interactions.

• Autophagy — Cancer's Escape Route — Cross-cancer hub on autophagy as a treatment-escape pathway, including the three-part trilogy on early intervention, stack design, and host protection.

B

• Biopsy Support; Before and After Care — Practical, evidence-aware support before and after biopsy—covering procedure choices, seeding and stress-response concerns, bleeding risks, sedation, supplement stop lists, recovery, urgent red flags, and clinician questions.

• Brain & Skull Met Monitoring Guide — This guide explains what common imaging tests are measuring, why results may not match exactly, and how to ask for focused comparison and follow-up

• Bone Metastases — Shared bone-metastasis hub covering actionable research summaries, standard bone-targeted therapies, integrative strategies, protocol notes, and community member experiences.

• Bone Health — Member-contributed bone-health hub covering DXA interpretation, lab work, diet, supplementation, exercise, and research notes.

• Berberine in Oncology — Evidence-based guide to berberine in oncology, including metabolism, microbial overlap, cancer-type evidence, and interaction cautions.

• Boswellia in Oncology — Evidence-based guide to Boswellia (frankincense) in oncology—covering AKBA, cancer-type evidence, tumour biology, brain-tumour oedema, absorption, dosing, safety, interactions, and sourcing.

• Books — Book recommendations for cancer patients, carers, and readers exploring integrative oncology, healing, metabolic approaches, repurposed drugs, and wider support.

• Breast Cancer — A hub for breast‑cancer resources, treatment‑resistance research summaries, metastatic support, and practical pathway tools for ER+, HER2‑positive and TNBC. Resources written by and for breast‑cancer patients, updated regularly. Contributors welcome.

C

• CDK4/6 Options and Supplement Considerations — Practical comparison of palbociclib, ribociclib, and abemaciclib in HR-positive, HER2-negative advanced breast cancer—covering efficacy, dosing, side effects, QTc, neutropenia, supplements, interactions, and monitoring.

• Cancer Patient Community Supports — Community support hub for people living with cancer, bringing together books, podcasts, online groups, discussion threads, trusted suppliers, discounts, and practical shared resources.

• Cancer Type Support and Discussion Threads A–Z — Community discussion threads organised by cancer type for Healing Cancer Study Support Group members.

• Cancer Therapies + Clinic Offerings — Treatment directories, clinic-based offerings, and integrative practitioner directories for New Zealand, Europe, and the UK.

• Cimetidine (Tagamet) in Oncology — Cimetidine's anti-metastatic and immune mechanisms.

• Conventional Drugs Support and Discussion Threads A–Z — Community discussion threads for standard oncology drugs, side effects, and practical patient support questions.

• Curcumin in Oncology — Explore curcumin in oncology: prevention and adjunctive-care evidence, inflammation and tumour-signalling pathways, evidence by cancer type, immune effects, enhanced formulations, dosing, safety, and drug interactions.

D

• Deuterium-Depleted Water (DDW) — Investigational metabolic adjunct in oncology, with pages on the overview, evidence by cancer type, the pancreatic study, lower-limit protocol debate, and practical sourcing.

• Dormant Cancer Cells — Cross-cancer guide to dormant cells and slow growing residual disease, treatment resistance and reactivation triggers, local-treatment questions, and team-discussion prompts.

• Drug Interaction Research: In Vitro vs. In Vivo — Plain-language guide to weighing laboratory and human supplement-interaction evidence, formulation differences, and practical safety questions.

E

• EGCG in Oncology — Evidence-based guide to EGCG, the main green-tea catechin studied in oncology—covering anticancer mechanisms, cancer-type evidence, immune effects, bioavailability, dosing, safety, interactions, and sourcing.

• ER-Positive / HER2-Negativer Breast Cancer Hub - Estrogen-receptor-positive/HER2-negative breast cancer research summaries that need their own treatment and resistance contexts.

F

• Fibrotic, Hard or "Cement‑Like" Lesions — A short guide for anyone noticing very hard, stiff, or "cement‑like" areas around tumours, outlining three layers — driver programme, fibrotic scaffold, and fibrin/perfusion — and where terrain‑level supports like melatonin, honokiol, flavonoids, nattokinase, lumbrokinase, bromelain and serrapeptase fit as adjuncts.

• Finding Your Support Team: A Guide to Integrative Cancer Care Practitioners — Guide to the main integrative cancer care practitioner types, what each can help with, and directories for finding qualified support worldwide.

• Fungal Pathogens — Fungal-pathogen support content, including protocol-building material and related resources.

H

• Heavy Metals & Cancer — Patient-facing guide to copper, heavy metal burden, pathogen overlap, testing choices, and practical next steps in oncology.

• HER2-Positive Breast Cancer Hub — HER2-positive breast-cancer topics that need their own treatment and resistance context

I

• Immunology Hub — Cancer immunotherapy, T-cell biology, gamma–delta T cells, macrophages, immune-cycle steps, biomarkers, R-Cu and cfChps and diet–gut-health research.

• Ivermectin in Cancer: a checklist for patients — Ivermectin in cancer: a simple checklist for a more informed look

• Ivermectin & ER+ Breast Cancer: What the 2026 Research Actually Found — Plain-language breakdown of the 2026 cell study showing ESR1/ERα, HER2, and pSMAD2 suppression, with confirmed tamoxifen synergy.

• Itraconazole in Oncology — Evidence-based overview of itraconazole in oncology, including mechanisms, cancer-type evidence, dosing, safety, and sourcing.

L

• Liposomal Encapsulation of Anti-cancer Compounds — Practical liposomal-delivery hub covering empty liposomes, safety, liposomal melatonin, liposomal ivermectin, and nebulising cautions.

• L. reuteri in Oncology — Evidence-aware guide to Limosilactobacillus reuteri in oncology, including preclinical tumour biology, immunotherapy relevance, yoghurt preparation, capsule options, and safety cautions.

M

• Macrophages in Cancer — Patient-facing guide to macrophages in cancer, including immune coordination, recovery time, and why washout windows can matter.

• Melatonin in Oncology - Study Notes — Study-note hub covering melatonin's mitochondrial, immune, phase-separation, fibrotic, and dosing questions in oncology research.

• Mebendazole in Oncology — Evidence-based overview of mebendazole in oncology, including mechanisms, cancer-type evidence, dosing, safety, immune effects, and sourcing.

N

• Natural Anti-Cancer Compounds & Molecules — Evidence-based library of deep dives on natural compounds and selected molecules, including Apigenin, Berberine, Boswellia, Curcumin, EGCG, Polydatin, Shikonin, Urolithin A, Withaferin A, Milk thistle, and Usnea. An A–Z index of study support group discussion threads on natural compounds and molecules is also found here.

• Neuropathy — Structured deep dive on treatment-related nerve damage, red flags, standard care, and integrative supports. Study group members recommendations from over the years including treatments, devices, nutraceuticals and topical formulas. R-ALA, Zoltaran and Lodacaine unpacked in more detail.

• Neutropenia — Low White Blood Cell Count — Direct deep dive on low neutrophils in cancer care, including chemotherapy-related, chronic, and post-treatment neutropenia.

O

• Off-Label Drugs for Cancer — Repurposed-drug hubs, such as mebendazole and itraconazole, with safety, interaction, and discussion-thread context.

P

• Pathogens — Structured anti-pathogen protocol supports.

• Podcasts — Podcast recommendations for cancer patients, carers, and integrative oncology learners, including healing stories, survivorship, and practical support.

• Polydatin in Oncology — Evidence-based overview of polydatin in oncology, including resveratrol-related mechanisms, cancer-type evidence, dosing, and safety.

• Pu‑erh tea — Evidence-aware guide to ripe Pu‑erh tea, theabrownin, metabolic terrain support, sourcing, and practical brewing.

R

• Resistant Starch — Practical guide to resistant starch, food preparation, butyrate production, and why cooling cooked starches can change both glycaemic and gut effects.

• R-Cu, Cell-Free Chromatin Particles and Immune Checkpoints — A detailed review of emerging research on the resveratrol–copper (R-Cu) protocol, including its reported effects on cell-free chromatin particles (cfChps), immune checkpoints and cancer-related biomarkers. It also clearly outlines the current evidence gaps and offers free community sourced information and resources.

S

• Senescence — The Second Escape Route — Cross-cancer hub on therapy-induced senescence, SASP biology, senolytic strategy, and treatment-survivor clean-up logic.

• Senolytic Pulse Protocol — This page is designed as a conservative, patient-facing framework for discussing intermittent natural senolytic-style pulses built around fisetin and quercetin, using currently available human dosing patterns as the foundation.

• Shikonin in Oncology — Evidence-based overview of shikonin in oncology, including PKM2 inhibition, estrogen-receptor degradation, resistance sensitisation, and cancer-type evidence.

• Side Effects — Cross-cancer side-effect, symptom-support, and recovery topics, including overview pages and deeper symptom guides.

• Symptoms - considerations beyond just the physical - listening to the parts of us that are frightened by what we’re asking our bodies to endure.

• Skull and Brain Mets - What common imaging tests are measuring, why results may not match exactly, and how to ask for focused comparison and follo

• Silymarin / Milk Thistle in Oncology — Evidence-based overview of silymarin and milk thistle in oncology, including liver support, cancer-type evidence, and interaction questions.

• Supplements - Trusted Suppliers and Discounts — Vetted supplement suppliers and discount codes for our cancer research support community — MCS Formulas, Fullscript, Welldium & more

• Surgery Support; Before and After Care — Evidence-based perioperative guidance for cancer patients before and after surgery, including anaesthesia questions, supplement pauses, wound healing support, and post-op red flags.

T

• Testing, Monitoring & Biomarkers — Testing ideas, biomarkers, bloodwork, and practical monitoring guidance.

• TP53 in Cancer — TP53 testing, mutation types, germline and somatic interpretation, and practical support questions.

• Testing & Diagnostics Discussion Threads A–Z — Community discussion threads on CT scans, DUTCH testing, genomic analysis and other diagnostic questions.

• The Felt Science of Thriving — Embodied support work, guided practices, and self-paced learning built around the twelve life energies.

• Treatment Resistance — Resistance mechanisms, progression patterns, dormancy, and treatment-exposure questions across cancer therapies.

U

• Urolithin A in Oncology — Evidence-based overview of Urolithin A in oncology, including mitophagy, immune effects, cancer-type evidence, pharmacokinetics, and safety questions.

• Usnic Acid / Usnea in Oncology — Evidence-based overview of usnic acid from Usnea, including anticancer mechanisms, antifungal crossover, dosing context, and safety cautions.

W

• Withaferin A (WFA) in Oncology — Evidence-based overview of withaferin A in oncology, including autophagy blockade, ER-α suppression, HSP90 disruption, pharmacokinetics, safety, and sourcing.

How to use this site

• Start with the section that best matches the kind of question you have.

• Use overview pages or directory pages first.

• Move into deeper pages only when you need more detail.

• Use the support and thriving sections alongside the evidence sections, not instead of them.

What this site is for

This site exists to help people:

• understand complex treatment and supplement questions more clearly

• find practical support that does not feel superficial

• locate structured, evidence-aware resources without getting lost

• hold together science, lived experience, and the deeper work of staying alive inside a difficult reality

© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.